我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无批准数据
- The CHELsea II trial, a groundbreaking cluster randomized study across 80 UK healthcare sites, aims to definitively evaluate the effects of clinically assisted hydration in patients' final days of life. - The study will assess whether maintaining hydration reduces delirium prevalence and impacts other end-of-life symptoms, targeting 1,600 participants over a two-year period ending September 2024. - This landmark trial addresses a critical evidence gap in palliative care, using standardized protocols for fluid administration and comprehensive 4-hourly patient assessments to measure outcomes.
